logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Patel, Kalpesh Kanubhai
    Pharmacist born in November 1959
    Individual (9 offsprings)
    Officer
    icon of calendar 2020-02-13 ~ now
    OF - Director → CIF 0
  • 2
    Patel, Amar Shilan Kalpesh
    Managing Director born in April 1991
    Individual (4 offsprings)
    Officer
    icon of calendar 2020-02-13 ~ now
    OF - Director → CIF 0
Ceased 3
  • 1
    Patel, Nehul
    Director born in March 1995
    Individual (1 offspring)
    Officer
    icon of calendar 2020-02-14 ~ 2020-02-15
    OF - Director → CIF 0
  • 2
    Patel, Chhaya Kalpesh
    Managing Director born in April 1962
    Individual (2 offsprings)
    Officer
    icon of calendar 2020-02-13 ~ 2020-02-15
    OF - Director → CIF 0
  • 3
    Patel, Minesh Kanubhai
    Director born in January 1956
    Individual (25 offsprings)
    Officer
    icon of calendar 2020-02-14 ~ 2020-02-15
    OF - Director → CIF 0
parent relation
Company in focus

NOVUSPHARMA (UK) LTD

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Cost of Sales
-9,381,471 GBP2023-07-01 ~ 2024-06-30
-6,250,915 GBP2022-07-01 ~ 2023-06-30
Administrative Expenses
-3,926,201 GBP2023-07-01 ~ 2024-06-30
-2,380,462 GBP2022-07-01 ~ 2023-06-30
Other Interest Receivable/Similar Income (Finance Income)
6,226 GBP2023-07-01 ~ 2024-06-30
1,975 GBP2022-07-01 ~ 2023-06-30
Profit/Loss on Ordinary Activities Before Tax
-38,273 GBP2023-07-01 ~ 2024-06-30
153,653 GBP2022-07-01 ~ 2023-06-30
Profit/Loss
-140,811 GBP2023-07-01 ~ 2024-06-30
64,716 GBP2022-07-01 ~ 2023-06-30
Intangible Assets
Goodwill
5,806,713 GBP2024-06-30
3,689,147 GBP2023-06-30
Property, Plant & Equipment
213,280 GBP2024-06-30
186,829 GBP2023-06-30
Fixed Assets
6,019,993 GBP2024-06-30
3,875,976 GBP2023-06-30
Debtors
1,248,082 GBP2024-06-30
1,095,988 GBP2023-06-30
Cash at bank and in hand
943,327 GBP2024-06-30
478,152 GBP2023-06-30
Current Assets
3,340,608 GBP2024-06-30
2,202,475 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-3,423,611 GBP2023-06-30
Net Current Assets/Liabilities
-813,390 GBP2024-06-30
-1,221,136 GBP2023-06-30
Total Assets Less Current Liabilities
5,206,603 GBP2024-06-30
2,654,840 GBP2023-06-30
Creditors
Non-current, Amounts falling due after one year
-2,053,073 GBP2023-06-30
Net Assets/Liabilities
422,664 GBP2024-06-30
563,475 GBP2023-06-30
Equity
Called up share capital
10,000 GBP2024-06-30
10,000 GBP2023-06-30
10,000 GBP2022-06-30
Retained earnings (accumulated losses)
412,664 GBP2024-06-30
553,475 GBP2023-06-30
488,759 GBP2022-06-30
Equity
422,664 GBP2024-06-30
563,475 GBP2023-06-30
Profit/Loss
Retained earnings (accumulated losses)
-140,811 GBP2023-07-01 ~ 2024-06-30
64,716 GBP2022-07-01 ~ 2023-06-30
Audit Fees/Expenses
8,000 GBP2023-07-01 ~ 2024-06-30
0 GBP2022-07-01 ~ 2023-06-30
Average Number of Employees
802023-07-01 ~ 2024-06-30
622022-07-01 ~ 2023-06-30
Wages/Salaries
1,732,241 GBP2023-07-01 ~ 2024-06-30
963,727 GBP2022-07-01 ~ 2023-06-30
Pension & Other Post-employment Benefit Costs/Other Pension Costs
30,581 GBP2023-07-01 ~ 2024-06-30
16,181 GBP2022-07-01 ~ 2023-06-30
Staff Costs/Employee Benefits Expense
1,901,018 GBP2023-07-01 ~ 2024-06-30
1,047,870 GBP2022-07-01 ~ 2023-06-30
Director Remuneration
82,667 GBP2023-07-01 ~ 2024-06-30
46,667 GBP2022-07-01 ~ 2023-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
6,433 GBP2023-07-01 ~ 2024-06-30
16,533 GBP2022-07-01 ~ 2023-06-30
Intangible Assets - Gross Cost
Goodwill
6,859,039 GBP2024-06-30
4,299,473 GBP2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
1,052,326 GBP2024-06-30
610,326 GBP2023-06-30
Intangible Assets - Increase From Amortisation Charge for Year
Goodwill
442,000 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
5,000 GBP2024-06-30
5,000 GBP2023-06-30
Furniture and fittings
320,903 GBP2024-06-30
240,966 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
364,625 GBP2024-06-30
277,724 GBP2023-06-30
Land and buildings, Under hire purchased contracts or finance leases
38,722 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
3,129 GBP2024-06-30
2,506 GBP2023-06-30
Furniture and fittings
143,876 GBP2024-06-30
86,597 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
151,345 GBP2024-06-30
90,895 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
623 GBP2023-07-01 ~ 2024-06-30
Furniture and fittings
57,279 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
60,450 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings, Under hire purchased contracts or finance leases
4,340 GBP2024-06-30
Property, Plant & Equipment
Land and buildings, Under hire purchased contracts or finance leases
34,382 GBP2024-06-30
Plant and equipment
1,871 GBP2024-06-30
2,494 GBP2023-06-30
Furniture and fittings
177,027 GBP2024-06-30
154,369 GBP2023-06-30
Finished Goods/Goods for Resale
1,149,199 GBP2024-06-30
628,335 GBP2023-06-30
Trade Debtors/Trade Receivables
Current
998,898 GBP2024-06-30
793,259 GBP2023-06-30
Other Debtors
Current
187,607 GBP2024-06-30
248,173 GBP2023-06-30
Prepayments/Accrued Income
Current
61,577 GBP2024-06-30
54,556 GBP2023-06-30
Debtors
Amounts falling due within one year, Current
1,248,082 GBP2024-06-30
Current, Amounts falling due within one year
1,095,988 GBP2023-06-30
Bank Borrowings/Overdrafts
Current
181,959 GBP2024-06-30
87,588 GBP2023-06-30
Trade Creditors/Trade Payables
Current
3,512,328 GBP2024-06-30
2,593,631 GBP2023-06-30
Corporation Tax Payable
Current
138,358 GBP2024-06-30
72,404 GBP2023-06-30
Other Taxation & Social Security Payable
Current
37,510 GBP2024-06-30
21,948 GBP2023-06-30
Other Creditors
Current
256,002 GBP2024-06-30
643,041 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
27,841 GBP2024-06-30
4,999 GBP2023-06-30
Creditors
Current
4,153,998 GBP2024-06-30
3,423,611 GBP2023-06-30
Bank Borrowings/Overdrafts
Non-current
4,739,214 GBP2024-06-30
2,053,073 GBP2023-06-30
Bank Borrowings
4,921,173 GBP2024-06-30
2,140,661 GBP2023-06-30
Total Borrowings
Current
181,959 GBP2024-06-30
87,588 GBP2023-06-30
Non-current
4,739,214 GBP2024-06-30
2,053,073 GBP2023-06-30
  • NOVUSPHARMA (UK) LTD
    Info
    Registered number 12461049
    icon of address64 High Street, Pinner HA5 5QA
    Private Limited Company incorporated on 2020-02-13 (5 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-16
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.